Literature DB >> 1096574

Indications of piribedil in L-DOPA-treated parkinsonian patients: physiopathologic implications.

P Rondot, N Bathien, J L Dumas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1096574

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  4 in total

1.  Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.

Authors:  R Pagliari; L Peyrin; O Crambes
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Activity and acceptability of piribedil in Parkinson's disease: a multicentre study.

Authors:  P Rondot; M Ziegler
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 3.  Parkinson's disease: pathological mechanisms and actions of piribedil.

Authors:  P Jenner
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

Review 4.  Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2016-08       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.